Cargando…
In vitro models of multiple system atrophy from primary cells to induced pluripotent stem cells
Multiple system atrophy (MSA) is a rare neurodegenerative disease with a fatal outcome. Nowadays, only symptomatic treatment is available for MSA patients. The hallmarks of the disease are glial cytoplasmic inclusions (GCIs), proteinaceous aggregates mainly composed of alpha‐synuclein, which accumul...
Autores principales: | Abati, Elena, Di Fonzo, Alessio, Corti, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908105/ https://www.ncbi.nlm.nih.gov/pubmed/29502349 http://dx.doi.org/10.1111/jcmm.13563 |
Ejemplares similares
-
Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectives
por: Monzio Compagnoni, Giacomo, et al.
Publicado: (2019) -
Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges
por: Ndayisaba, Alain, et al.
Publicado: (2019) -
Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases
por: Abati, Elena, et al.
Publicado: (2022) -
Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy
por: Monzio Compagnoni, Giacomo, et al.
Publicado: (2018) -
Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies
por: Salani, Sabrina, et al.
Publicado: (2012)